StartAngels Network

Type

Angel Group/Syndicate

Status

Active

Location

Zurich, Switzerland

Total investments

27

Average round size

2M

Portfolio companies

20

Rounds per year

1.17

Lead investments

5

Follow on index

0.26

Exits

3

Stages of investment
Late Stage Venture
Areas of investment
BiotechnologySoftwareFinanceHealth CareRoboticsManufacturingMedical DeviceMedicalPharmaceuticalNavigation

Summary

StartAngels Network is the famous Corporate Investor, which was founded in 2000. The main department of described Corporate Investor is located in the Zu00fcrich. The fund was located in Europe if to be more exact in Switzerland.

Besides, a startup needs to be aged 2-3 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Biotechnology, Medical. For fund there is a match between the location of its establishment and the land of its numerous investments - Switzerland. Among the various public portfolio startups of the fund, we may underline Hylomorph, Bluetector, Viroblock The fund has specific favorite in a number of founders of portfolio startups. When startup sums 4 or 5+ of the founder, the probability for it to get the investment is little.

The usual things for fund are deals in the range of 1 - 5 millions dollars. Comparing to the other companies, this StartAngels Network performs on 16 percentage points less the average number of lead investments. The fund is constantly included in less than 2 deals per year. The real fund results show that this Corporate Investor is 5 percentage points more often commits exit comparing to other companies. The top activity for fund was in 2012.

The typical case for the fund is to invest in rounds with 2-3 participants. Despite the StartAngels Network, startups are often financed by Zu00fcrcher Kantonal Bank, Venture Kick, Initiative Capital Romandie. The meaningful sponsors for the fund in investment in the same round are Zu00fcrcher Kantonal Bank, investiere | Verve Capital Partners, Aargauische Kantonalbank. In the next rounds fund is usually obtained by investiere | Verve Capital Partners, Zu00fcrcher Kantonal Bank, Zu00fcrcher Kantonalbank ZKB.

Show more

Investor highlights

Stage focus
Seed

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Analytics

Total investments
27
Lead investments
5
Exits
3
Rounds per year
1.17
Follow on index
0.26
Investments by industry
  • Medical Device (13)
  • Medical (10)
  • Health Care (8)
  • Manufacturing (6)
  • Navigation (4)
  • Show 43 more
Investments by region
  • Switzerland (26)
  • Brazil (1)
Peak activity year
2022

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
9
Avg. valuation at time of investment
800K
Group Appearance index
0.85
Avg. company exit year
6

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Attolight 31 Oct 2012 Medical Device, Medical, Nanotechnology Early Stage Venture 1M Switzerland, Vaud, Lausanne
Hylomorph 05 Sep 2023 Health Care, Medical Device, Medical Early Stage Venture 4M Switzerland, Zurich, Zurich
Muck Rack 07 Sep 2022 Software, Information Services, SaaS, Public Relations, Media and Entertainment, Journalism Early Stage Venture 180M United States, Florida, Miami
Tapas Media 15 Nov 2012 Publishing, Mobile, Content Seed 750K United States, California

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.